Publications by authors named "C Pribil"

Claim this Profile
[
[Use of fluticasone/umeclidinium/vilanterol in France: A population based study].
B Aguilaniu, J Cittee, L Watier, C Pribil, G Nachbaur

Rev Mal Respir· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Public Health Impact and Cost-Effectiveness Analysis of 4-Component Meningococcal Serotype B Vaccination for Infants in France.
Gérard de Pouvourville, Manon Breau-Brunel, Véronique Loncle-Provot, Ekkehard Beck, Loïg Gaugain, Céline Pribil

Pharmacoecon Open· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Care pathways in invasive meningococcal disease: a retrospective analysis of the French national public health insurance database.
Catherine Weil-Olivier, Muhamed-Kheir Taha, Stéphane Bouée, Corinne Emery, Véronique Loncle-Provot, Céline Pribil

Hum Vaccin Immunother· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare Resource Consumption and Cost of Invasive Meningococcal Disease in France: A Study of the National Health Insurance Database.
Catherine Weil-Olivier, Muhamed-Kheir Taha, Corinne Emery, Stéphane Bouée, Ekkehard Beck, Céline Pribil

Infect Dis Ther· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for invasive meningococcal disease: a retrospective analysis of the French national public health insurance database.
Muhamed-Kheir Taha, Catherine Weil-Olivier, Stéphane Bouée, Corinne Emery, Gaëlle Nachbaur, Céline Pribil

Hum Vaccin Immunother· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis